SCHEMBL4463848

SCHEMBL4463848

Fc1ccc(-c2noc(-c3cccnc3)n2)cc1.N/C(=N\O)c1ccc(F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.58
TP53 P04637 6/20 0.58
CHRNB2 P17787 3/20 0.57
CHRNA5 P30532 3/20 0.57
CHRNA4 P43681 3/20 0.57
S1PR1 P21453 2/20 0.56
NPC1 O15118 10/20 0.52
RAB9A P51151 10/20 0.52
MAPT P10636 5/20 0.52
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 2/20 0.52
KDM4E B2RXH2 1/20 0.52
HPGD P15428 1/20 0.52
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
CA9 Q16790 1/20 0.49
POLB P06746 1/20 0.48
TSHR P16473 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4463851 1.00 SMN1; SMN2 (0.58) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL1423487 0.86 SMN1; SMN2 (0.77) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL1422602 0.81 NPC1 (0.77) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL8051460 0.76 SMN1; SMN2 (0.77) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL3796996 0.75 SMN1; SMN2 (1.00) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL1422890 0.75 CHRNB2 (1.00) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL12171589 0.75 SMN1; SMN2 (0.75) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL5959951 0.74 SMN1; SMN2 (0.84) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL4456725 0.73 CA9 (0.55) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4
SCHEMBL4456727 0.73 CA9 (0.55) SMN1; SMN2TP53CHRNB2CHRNA5CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101763-A2 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE Abbott Laboratories (US) 2009-09-23 EP disclosed
WO-2008073942-A2 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-06-19 WO disclosed